CAMBRIDGE, Mass., Dec. 27 /PRNewswire-FirstCall/ -- Millennium
Pharmaceuticals, Inc. (Nasdaq: MLNM) will hold a live webcast of a
conference call at 8:00 a.m. ET on Friday, January 4, 2008 in advance of
the 26th Annual JPMorgan Healthcare Conference. Dr. Deborah Dunsire,
president and chief executive officer of Millennium, will host the call.
She will discuss the Company's key accomplishments in 2007 and goals and
financial guidance for 2008.
(Logo: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO )
The live webcast can be accessed by visiting the Investors section of
the Company's website, http://www.millennium.com. Following the webcast, an
archived version of the call will be available at the same address for 30
days.
About Millennium
Millennium Pharmaceuticals, Inc., a leading biopharmaceutical company
based in Cambridge, Mass., markets VELCADE(R) (bortezomib) for Injection, a
novel cancer product, and has a robust clinical development pipeline of
product candidates. The Company's research, development and
commercialization activities are focused in two therapeutic areas: oncology
and inflammation. By applying its knowledge of the human genome,
understanding of disease mechanisms and industrialized drug discovery
platform, Millennium is developing an exciting pipeline of innovative
product candidates. The Company's website is http://www.millennium.com.
Editors' Note: This press release is also available under the Media
section of the Company's website at: http://www.millennium.com.
Contact:
Kyle Kuvalanka
(617) 761-4734
SOURCE Millennium Pharmaceuticals, Inc.
 back to top
Related links:
http://www.millennium.com
Photo Notes:
NewsCom: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO
AP Archive: http:
http://www.prnewswire.com/comp/114562.html/
CONTACT:
Kyle Kuvalanka of Millennium Pharmaceuticals,
Inc., +1-617-761-4734
|
